---
figid: PMC9479759__fphar-13-986963-g005
figtitle: Therapeutic potential of WKYMVm in diseases
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC9479759
filename: fphar-13-986963-g005.jpg
figlink: /pmc/articles/PMC9479759/figure/F5/
number: F5
caption: WKYMVm with insulin resistance, osteolytic diseases and neurodegenerative
  diseases. WKYMVm ameliorates insulin resistance by sensitizing the insulin pathway
  in metabolic tissues (skeletal muscle and liver), and modulating the expression
  of inflammatory cytokines in white adipose tissue. WKYMVm alleviates osteolysis
  by inhibiting the formation of osteoclasts, directly through NF-κB and STAT3 signaling
  pathway and indirectly through CD9/gp130/STAT3 pathway. WKYMVm promotes the proliferation,
  expansion, chemotactic migration and viability of NSCs to alleviate neurodegenerative
  diseases. p-Akt, Akt phosphorylation; p-PKC-θ, protein kinase C-θ phosphorylation;
  p-IRS1, insulin receptor substrate 1 phosphorylation; IL, interleukin; TNF-α, tumor
  necrosis factor alpha; CCL2, C-C motif chemokine ligand 2; gp130, glycoprotein 130;
  p-STAT3, signal transducer and activator of transcription 3 phosphorylation; p-NF-κB,
  nuclear factor-kappa B phosphorylation; NSC, neural stem cell. ↑, increase; ↓, decrease.
papertitle: Therapeutic potential of WKYMVm in diseases.
reftext: Huan Ma, et al. Front Pharmacol. 2022;13:986963.
year: '2022'
doi: 10.3389/fphar.2022.986963
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: WKYMVm | FPRs | inflammation | cancer | angiogenesis
automl_pathway: 0.9478227
figid_alias: PMC9479759__F5
figtype: Figure
redirect_from: /figures/PMC9479759__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9479759__fphar-13-986963-g005.html
  '@type': Dataset
  description: WKYMVm with insulin resistance, osteolytic diseases and neurodegenerative
    diseases. WKYMVm ameliorates insulin resistance by sensitizing the insulin pathway
    in metabolic tissues (skeletal muscle and liver), and modulating the expression
    of inflammatory cytokines in white adipose tissue. WKYMVm alleviates osteolysis
    by inhibiting the formation of osteoclasts, directly through NF-κB and STAT3 signaling
    pathway and indirectly through CD9/gp130/STAT3 pathway. WKYMVm promotes the proliferation,
    expansion, chemotactic migration and viability of NSCs to alleviate neurodegenerative
    diseases. p-Akt, Akt phosphorylation; p-PKC-θ, protein kinase C-θ phosphorylation;
    p-IRS1, insulin receptor substrate 1 phosphorylation; IL, interleukin; TNF-α,
    tumor necrosis factor alpha; CCL2, C-C motif chemokine ligand 2; gp130, glycoprotein
    130; p-STAT3, signal transducer and activator of transcription 3 phosphorylation;
    p-NF-κB, nuclear factor-kappa B phosphorylation; NSC, neural stem cell. ↑, increase;
    ↓, decrease.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT2
  - AKT3
  - IRS1
  - IL6
  - TNF
  - IL1B
  - CD9
  - IL6ST
  - NM
  - LRPPRC
  - STAT3
  - NFKB1
  - irs1
  - il6
  - tnfb
  - il1b
  - cd9a
  - ighv1-1
  - il6st
  - stat3
---
